BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 33920096)

  • 1. Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization.
    Filipska I; Winiarska A; Knysak M; Stompór T
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33920096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uremic Vascular Calcification: The Pathogenic Roles and Gastrointestinal Decontamination of Uremic Toxins.
    Chao CT; Lin SH
    Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33371477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of CKD on Uremic Toxins and Gut Microbiota.
    Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease.
    Black AP; Cardozo LF; Mafra D
    Ther Apher Dial; 2015 Oct; 19(5):436-40. PubMed ID: 25944654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression.
    Castillo-Rodriguez E; Fernandez-Prado R; Esteras R; Perez-Gomez MV; Gracia-Iguacel C; Fernandez-Fernandez B; Kanbay M; Tejedor A; Lazaro A; Ruiz-Ortega M; Gonzalez-Parra E; Sanz AB; Ortiz A; Sanchez-Niño MD
    Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30029499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular Calcification: An Important Understanding in Nephrology.
    Zununi Vahed S; Mostafavi S; Hosseiniyan Khatibi SM; Shoja MM; Ardalan M
    Vasc Health Risk Manag; 2020; 16():167-180. PubMed ID: 32494148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Chronic Kidney Disease and Uremic Toxins on Extracellular Vesicle Biology.
    Yaker L; Kamel S; Ausseil J; Boullier A
    Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33371311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay between gut microbiota, bone health and vascular calcification in chronic kidney disease.
    Rodrigues FG; Ormanji MS; Heilberg IP; Bakker SJL; de Borst MH
    Eur J Clin Invest; 2021 Sep; 51(9):e13588. PubMed ID: 33948936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins.
    Lau WL; Savoj J; Nakata MB; Vaziri ND
    Clin Sci (Lond); 2018 Mar; 132(5):509-522. PubMed ID: 29523750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut-Derived Protein-Bound Uremic Toxins.
    Graboski AL; Redinbo MR
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32932981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolome and Its Emerging Role in Chronic Kidney Diseases.
    Fryc J; Naumnik B
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33803899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uremic Toxins and Vascular Calcification-Missing the Forest for All the Trees.
    Rapp N; Evenepoel P; Stenvinkel P; Schurgers L
    Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 33003628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Uremic Toxins in Early Vascular Ageing and Calcification.
    Kyriakidis NC; Cobo G; Dai L; Lindholm B; Stenvinkel P
    Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33401534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial.
    Ramos CI; Armani RG; Canziani MEF; Dalboni MA; Dolenga CJR; Nakao LS; Campbell KL; Cuppari L
    Nephrol Dial Transplant; 2019 Nov; 34(11):1876-1884. PubMed ID: 29939302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.
    Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T
    Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gut-kidney axis.
    Evenepoel P; Poesen R; Meijers B
    Pediatr Nephrol; 2017 Nov; 32(11):2005-2014. PubMed ID: 27848096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Link between gut microbiota dysbiosis and chronic kidney disease.
    Noce A; Marchetti M; Marrone G; Di Renzo L; Di Lauro M; Di Daniele F; Albanese M; Di Daniele N; De Lorenzo A
    Eur Rev Med Pharmacol Sci; 2022 Mar; 26(6):2057-2074. PubMed ID: 35363356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.
    Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G
    Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P
    Kamprom W; Tawonsawatruk T; Mas-Oodi S; Anansilp K; Rattanasompattikul M; Supokawej A
    Int J Med Sci; 2021; 18(3):744-755. PubMed ID: 33437209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphate, Microbiota and CKD.
    Favero C; Carriazo S; Cuarental L; Fernandez-Prado R; Gomá-Garcés E; Perez-Gomez MV; Ortiz A; Fernandez-Fernandez B; Sanchez-Niño MD
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33924419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.